Health Challenges and Solutions in Pediatric Endocrine Disease: Early Prevention and Management
A special issue of Children (ISSN 2227-9067).
Deadline for manuscript submissions: 5 December 2025 | Viewed by 8
Special Issue Editors
Interests: pediatric endocrinology; childhood obesity; adrenal disease in childhood
Interests: pediatric endocrinology; childhood obesity; minipuberty
Special Issue Information
Dear Colleagues,
In recent years, significant progress has been made in management strategies for pediatric endocrine disorders.
A key aspect of these advances is the improvement in diagnostic techniques, which has enabled easier access to advanced investigations, such as genetic analysis. These tools have not only deepened our understanding of many endocrine diseases but have also improved our capacity for early diagnosis and personalized therapies.
The enhanced knowledge of childhood growth disorders and obesity (both in early prevention and treatment) has transformed the clinical management of affected patients.
This Special Issue aims to address the diagnostic and therapeutic challenges that characterize these disorders. We invite original research articles, systematic or narrative reviews, and clinically relevant case reports with literature reviews focusing on early identification and prevention strategies, novel biomarkers, and advances in genetic and hormonal profiling. Special consideration will be given to works exploring the most pressing clinical challenges and proposing innovative solutions in pediatric endocrinology.
Dr. Letteria Anna Morabito
Dr. Giorgia Pepe
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pediatric endocrine disease
- diagnostic challenges
- genetic investigations
- new therapies in childhood obesity
- early prevention of childhood obesity
- growth disorders
- genetic and hormonal profiling
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.